Oncotherapy Resources Limited provides a mobile managed intraoperative radiotherapy service for early breast cancer. SD-IORT enables hospitals to offer patients ‘one dose, one treatment, one day’ radiotherapy option for early breast cancer employing cutting-edge technology, without the need for capital equipment purchase, maintenance costs or service charges, and at a low fee per patient.
http://www.oncotherapyresources.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
15 seconds
16x16
care Capital
ina ottmann
1●5
daw●●●oad
lo●●on , SW6 7EA
United Kingdom
View this contact
care Capital
ina ottmann
1●5
daw●●●oad
lo●●on , SW6 7EA
United Kingdom
View this contact
Elentaris I.T. Ltd
Mark Pickover
Cae●●●ryn
Bro●●●est , SA38 9ER
United Kingdom
View this contact
BUY YOUR DOMAIN
13
YEARS
9
MONTHS
25
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
14
SSL
EXTERNAL LINKS
3
SITE IP
185.13.244.142
LOAD TIME
14.954 sec
SCORE
6.2
SD-IORT > Home | oncotherapyresources.com Reviews
https://oncotherapyresources.com
Oncotherapy Resources Limited provides a mobile managed intraoperative radiotherapy service for early breast cancer. SD-IORT enables hospitals to offer patients ‘one dose, one treatment, one day’ radiotherapy option for early breast cancer employing cutting-edge technology, without the need for capital equipment purchase, maintenance costs or service charges, and at a low fee per patient.
oncotherapyresources.com
SD-IORT > For the Healthcare Professional > Patient Suitability
http://oncotherapyresources.com/Clinicians/Who-is-suitable-for-SD-IORT
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available?
User Log In
http://oncotherapyresources.com/Hospitals/Hospital-marketing-toolkit
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available?
How to book SD-IORT
http://oncotherapyresources.com/Hospitals/How-to-book-SD-IORT
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available?
SD-IORT > For the Healthcare Professional > Links and resources
http://oncotherapyresources.com/Clinicians/What-are-clinicians-saying
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available?
User Log In
http://oncotherapyresources.com/Hospitals
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is this treatment available? For the Healthcare Professional. Information on the system. Where is SD-IORT available?
TOTAL PAGES IN THIS WEBSITE
14
Partners
http://www.gulmaymedical.com/partners.aspx
Xstrahl enjoys strong working relationships with partners in the Medical, Life Sciences and Biology Radiation Fields. Xstrahl Ltd recently acquired Oncotherapy Resources Ltd (ORL). Through this acquisition, Xstrahl aims to strengthen its position as a leading provider of radiotherapy systems and services. Xstrahl’s experience in the UK radiotherapy market will allow ORL to provide a greater number of treatment options for UK patients suffering from cancer. Xstrahl launch E-Learning Portal.
Partners
http://www.xstrahl.com/partners.aspx
Xstrahl enjoys strong working relationships with partners in the Medical, Life Sciences and Biology Radiation Fields. Xstrahl Ltd recently acquired Oncotherapy Resources Ltd (ORL). Through this acquisition, Xstrahl aims to strengthen its position as a leading provider of radiotherapy systems and services. Xstrahl’s experience in the UK radiotherapy market will allow ORL to provide a greater number of treatment options for UK patients suffering from cancer.
TOTAL LINKS TO THIS WEBSITE
3
Oncotherapeutics
Full Service Contract Research Organization (CRO). Oncotherapeutics offers a comprehensive service portfolio that supports preclinical studies and clinical trials from phase I to IV. We strive to provide high quality deliverables and our clients, from small start-up biotech (16-50 employees) to large biotechnology and pharmaceuticals (10,000 employees), enjoy the benefits of our proactive, specialized approach. MEDNET Solutions Welcomes Oncotherapeutics to the MEDNET Partner Program. Website Design by AI...
OncoTherapy Science, Inc.
がん特異的ペプチドワクチン S-588410 第 相臨床試験進捗 最終患者登録 に関するお知らせ. 当社連結子会社と Thermo Fisher Scientific との新規リキッドバイオプシープラットフォーム評価のための提携についてのお知らせ. オンコセラピー サイエンス OTS では、がん分子標的治療薬の開発に適した標的遺伝子を多数同定しています。 血液 組織などの検体中に存在しているT細胞のTCR遺伝子配列情報を、次世代シーケンサーを用いて網羅的に取得し詳細に解析する T細胞受容体 TCR 解析サービス。 私たちは、 より治療効果が高く、より副作用の少ないがん治療薬 治療法を、一日も早くがんに苦しむ患者さんに届けること、がんとの闘いに勝つこと を目指し、ジェノミックスを医療分野に先駆者としてもたらした中村祐輔教授とともに、研究 開発に取り組んでいます。
US OncoTherapy systems BioMedicine Group
Oncotherapy Network
We've noticed that you're using an ad blocker. Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker. How do I disable my ad blocker? How to disable your ad blocker for our site:. Adblock / Adblock Plus. Click on the AdBlock / AdBlock Plus icon on the top right of your browser. Click Don’t run on pages on this domain. OR Enabled on this site. Close this help box and click "It's off now". Dec 21, 2017.
SD-IORT > Home
How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? How to book SD-IORT. Information for existing users. Early stage breast cancer. Am I suitable for SD-IORT? How does SD-IORT work? Where is SD-IORT available? For the Healthcare Professional. Information on the system. Where is SD-IORT available? You are here: Home.
Home Page
Focusing on scientific discovery and innovation in targeted therapy and immuno-oncology to save human lives:. Cancer is the second most common cause of death in the US, exceeded only by heart disease. One of every four deaths in the United States is due to cancer. The American Cancer Society estimates that in 2014, about 1,665,540 Americans were diagnosed with invasive cancer, and 585,720 Americans died of this disease. The company currently has three preclinical programs:. Preclinical studies of these d...
Oncotherex | Cancers du sein et de l'ovaire
Cancers du sein et de l'ovaire. Cancers du sein et de l'ovaire. Oncotherex est spécialisée dans la mise en culture de tumeurs du sein et de l'ovaire permettant de tester l'efficacité thérapeutique de molécules innovantes. En savoir plus sur Oncotherex. Vous êtes une start-up, un laboratoire académique ou une entreprise pharmaceutique et vous souhaitez tester des molécules innovantes, venez vite découvrir nos offres. Oncotherex propose de nombreux tests sur ses tumeurs du sein et de l'ovaire. Bienvenue su...
OncoTherics News
Latest news and events from Oncotherics. Wednesday, 17 December 2014. OncoTherics signs collaboration agreement with University of Cambridge. OncoTherics has signed a collaboration agreement with the University of Cambridge to progress a series of novel preclinical investigations using OCT1002 in Pancreatic Tumour models. The investigations will augment OncoTherics formal preclinical studies, providing useful additional information about OCT1002 in Pancreatic Cancer. Wednesday, 16 July 2014. Weiss Medall...
Oncotherix / InCell-RT™
Oncotherix™ is a clinical stage oncology company developing InCell-RT™. Herapy) for the treatment of locally-advanced cancers. InCell-RT is DNA-ligated nanometer-scale intracellular radiotherapy locally administered via catheter-based infusion systems. Oncotherix is developing InCell-RT as a safer and more effective treatment for numerous locally-advanced cancers, starting with recurrent ovarian cancer and high grade glioma brain cancer. Therapeutic Advantages of InCell-RT. 12635 E. Montview Blvd.
SOCIAL ENGAGEMENT